IOVS Clinical Microbiology Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2007;48:3655-3661.)
© 2007 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.06-1121

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, X. Y.
Right arrow Articles by Healey, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, X. Y.
Right arrow Articles by Healey, P. R.

Interferon-{alpha} and Interferon-{gamma} Sensitize Human Tenon Fibroblasts to Mitomycin-C

Xiao Yang Wang,1 Jonathan G. Crowston,1,2 Hans Zoellner,3 and Paul R. Healey1

1From the Center for Vision Research, University of Sydney, Westmead, Hospital Sydney, NSW, Australia; the 2Center for Eye Research Australia, University of Melbourne, East Melbourne, Australia; and the 3Department of Oral Pathology and Oral Medicine, Cellular and Molecular Research Unit, University of Sydney, Sydney, Australia.

PURPOSE. To investigate the effect of interferon (IFN)-{alpha} and IFN-{gamma} pretreatment on mitomycin C (MMC)–induced cell death in human Tenon fibroblasts (HTFs) and the mechanisms by which IFN-{alpha} and IFN-{gamma} modulate the susceptibility of HTFs to MMC.

METHODS. HTFs were pretreated with IFN-{alpha} and IFN-{gamma} for 48 hours before 5-minute application of 0.4 mg/mL MMC. Cell death after 48 hours was determined by Annexin V/propidium iodide (PI) staining and lactate dehydrogenase (LDH) release assay. Fas, Fas-ligand, and Bcl-2 expression were determined by flow cytometry. Fas associated death domain (FADD), Bax, cytochrome c, and caspase expression were determined by Western blot analysis and immunofluorescence staining.

RESULTS. MMC treatment increased cell death and upregulated Fas and FADD expression, but had no effect on Fas-Ligand, Bax, Bcl-2, or cytochrome c. Neither IFN-{alpha} nor IFN-{gamma} alone induced HTF death, but each increased cell death 2 days after MMC treatment in a dose-dependent fashion. Combination IFN-{alpha} and IFN-{gamma} had a synergistic effect. IFN-{alpha} and IFN-{gamma} pretreatment increased Fas expression. Fas upregulation was associated with increased sensitivity to MMC. IFN pretreatment increased procaspase-8, procaspase-9, and procaspase-3 expression, and caspase-3 activation. Caspase-8, caspase-3, and broad caspase inhibitors, but not caspase-9 inhibitor, inhibited MMC-induced cell death in nonpretreated and IFN-pretreated cells.

CONCLUSIONS. IFN-{alpha} and IFN-{gamma} enhance the susceptibility of HTFs to MMC-induced cell death through a Fas-mediated and a caspase-3–dependent pathway. Pretreatment with IFN primed HTFs to MMC, providing a potential means for initially slowing the healing response with IFN and subsequently terminating fibroblast activity through MMC-induced cell death.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Association for Research in Vision and Ophthalmology